{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:15:01Z","timestamp":1760645701153},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.neulet.2009.11.014","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T05:59:02Z","timestamp":1258091942000},"page":"287-291","source":"Crossref","is-referenced-by-count":14,"title":["Impaired transmethylation potential in Parkinson's disease patients treated with l-Dopa"],"prefix":"10.1016","volume":"468","author":[{"given":"Maria Luigia","family":"De Bonis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Tessitore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Pellecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ingrosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Zappia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioacchino","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2009.11.014_bib1","series-title":"S-Adenosylmethionine-dependent methyltransferases: structures and functions","first-page":"123","author":"Banfield","year":"1999"},{"key":"10.1016\/j.neulet.2009.11.014_bib2","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/mds.21997","article-title":"Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients","volume":"23","author":"Barone","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2009.11.014_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.22227","article-title":"Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients","volume":"24","author":"Camicioli","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2009.11.014_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)78090-9","article-title":"Acute hyperhomocysteinaemia and endothelial dysfunction","volume":"351","author":"Chambers","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2009.11.014_bib5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1006\/exnr.1997.6466","article-title":"Levels of l-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease","volume":"145","author":"Cheng","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2009.11.014_bib6","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.2174\/092986707781745613","article-title":"Homocysteine and cerebral stroke in developing countries","volume":"14","author":"Christopher","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neulet.2009.11.014_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2009.11.014_bib8","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1111\/j.1742-4658.2007.06048.x","article-title":"Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome","volume":"274","author":"Galletti","year":"2007","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.neulet.2009.11.014_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2009.11.014_bib10","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1001\/jama.288.16.2023","article-title":"MTHFR 677C\u2192T polymorphism and risk of coronary heart disease: a meta-analysis","volume":"288","author":"Klerk","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.neulet.2009.11.014_bib11","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J. Neurosci."},{"issue":"Suppl. 3","key":"10.1016\/j.neulet.2009.11.014_bib12","doi-asserted-by":"crossref","first-page":"S580","DOI":"10.1002\/mds.22037","article-title":"Pharmacokinetics and pharmacodynamics of levodopa","volume":"23","author":"Nutt","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2009.11.014_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","article-title":"Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations","volume":"61","author":"O'Suilleabhain","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2009.11.014_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ki.1996.324","article-title":"Membrane protein damage and methylation reactions in chronic renal failure","volume":"50","author":"Perna","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.neulet.2009.11.014_bib15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.WNL.0000137886.74175.5A","article-title":"Homocysteine and levodopa: should Parkinson disease patients receive preventive therapy?","volume":"63","author":"Postuma","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2009.11.014_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2006.05.040","article-title":"Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease","volume":"404","author":"Religa","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2009.11.014_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","article-title":"Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease","volume":"60","author":"Rogers","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2009.11.014_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2009.11.014_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jns.2006.05.040","article-title":"Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy","volume":"248","author":"Todorovic","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2009.11.014_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0404.2003.00135.x","article-title":"Levodopa-induced hyperhomocysteinaemia in Parkinson's disease","volume":"108","author":"Yasui","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neulet.2009.11.014_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exnr.2001.7726","article-title":"l-Dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase","volume":"171","author":"Zhao","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2009.11.014_bib22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/mds.22511","article-title":"Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia","volume":"24","author":"Zoccolella","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2009.11.014_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.parkreldis.2004.07.008","article-title":"Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications","volume":"11","author":"Zoccolella","year":"2005","journal-title":"Park. Rel. Dis."},{"key":"10.1016\/j.neulet.2009.11.014_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1515\/CCLM.2006.143","article-title":"Elevated plasma homocysteine levels in l-Dopa-treated Parkinson's disease patients with dyskinesias","volume":"44","author":"Zoccolella","year":"2006","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394009014803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394009014803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:41:32Z","timestamp":1558629692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394009014803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0304394009014803"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2009.11.014","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}